RxElite, Inc.
RXEI
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | -246.69% | 8.12% | -218.77% | -132.06% | -126.31% |
| Total Depreciation and Amortization | 490.26% | 1,271.22% | 1,128.27% | 250.59% | 1,364.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,998.68% | -53.28% | 16,602.67% | 134.32% | 101.25% |
| Change in Net Operating Assets | 124.33% | 474.94% | 96.48% | 385.75% | -927.83% |
| Cash from Operations | 86.63% | 33.53% | 45.44% | 131.97% | -7,014.79% |
| Capital Expenditure | -146.95% | 121.82% | -3,942.68% | -295.76% | 5,022.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -146.95% | 147.04% | -4,054.15% | -295.76% | 5,022.73% |
| Total Debt Issued | -- | -- | -- | 2,182.61% | -- |
| Total Debt Repaid | 80.23% | -21.94% | 28.96% | 82.82% | -3,135.12% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -1,830.09% | -- |
| Cash from Financing | -101.68% | -1.60% | -103.54% | 156.89% | 38,267.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15,654.76% | 607.02% | -430.70% | 970.59% | 106.10% |